MENU
TVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Travere Therapeutics (TVTX) Ownership - Who owns Travere Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
3611 Valley Centre Drive
Phone
+1 888 969-7879
Employees
380
Web
https://www.travere.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.49B
P/E Ratio
N/A
Total Cash
277.44M
Projected Growth
N/A
Total Debt
402.43M
Revenue
203.45M
Risk (Beta)
0.77
Dividend Yield
N/A
Total Cash/Share
3.19
Total Debt/Equity
N/A
Revenue/Share
2.63 USD as % of share price
Fundamentals
TVTX
Capitalization
1.49B
P/E Ratio
N/A
Risk (Beta)
0.77
Dividend Yield
N/A
Total Cash
277M
Total Cash/Share
3.19
Total Debt
402M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.63%
Revenue
203M
ROE
N/A
Book Value
-30.45M
P/B Ratio
70.42
Cash Flow
N/A
Earnings
-4.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
1.71
Current Revenue Per Employee
165521.05
Dividends Per Share - Security
N/A
EBITDA
-296.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
97.41
Revenue To Assets
-52.56
Shares Held By Institutions
2.71B
Shares Outstanding - Current
87M
Total Liabilities
535M
Total Volume MTD
N/A
Value
-1
Gain YTD
90.545
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which develops pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3611 Valley Centre Drive
Phone
+1 888 969-7879
Employees
380
Web
https://www.travere.com